Non-clinical Evaluation of NT-175, an Autologous T Cell Product Engineered to Express an HLA-A*02:01-restricted TCR Targeting TP53 R175H and Resistant to TGF-b Inhibition.

Vanessa Tubb,Jennifer Ma, Karen Buchner, Sander Eshuis, Michelle Mojadidi,Xiangjun Kong, Paula Kroon, Aastha Sareen, Rojina Duwal, Laura Bies, Julia Walker,Robbert Spaapen, Bas Stringer,Oscar Krijgsman, Helicia Paz-Chang, Yoonjung Shin,Thomas Kuilman, Jeroen van Heijst,Gavin Bendle, Arianne Perez

JOURNAL OF CLINICAL ONCOLOGY（2024）

Cited 0|Views2

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined